Thu, January 23, 2025
Wed, January 22, 2025
Tue, January 21, 2025
Mon, January 20, 2025
Sun, January 19, 2025
Sat, January 18, 2025
Fri, January 17, 2025
Thu, January 16, 2025
Wed, January 15, 2025

Should You Buy the Dip in Eli Lilly Stock Right Now?


//business-finance.news-articles.net/content/202 .. ou-buy-the-dip-in-eli-lilly-stock-right-now.html
Published in Business and Finance on by AOL   Print publication without navigation

All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq Composite. Unfortunately, Lilly investors haven't had much to celebrate so far in 2025. On Jan. 14, shares of Lilly dropped by as much as 8% and ended the day down around 6%. Year-to-date, share prices are down about 1.4%.

The article from AOL Finance discusses whether it's a good time to invest in Eli Lilly stock following a recent dip. Eli Lilly, a major pharmaceutical company, has experienced a decline in its stock price despite positive developments such as the FDA approval of its Alzheimer's drug, Donanemab, and strong sales of its diabetes drug, Mounjaro. The article highlights that while the stock has fallen, Eli Lilly's future looks promising due to its robust pipeline of new drugs and treatments. Analysts suggest that the dip could be an opportunity for long-term investors, given the company's potential for growth, its innovation in treatments for obesity, diabetes, and Alzheimer's, and its consistent performance in earnings. However, the article also notes concerns like competition, pricing pressures, and regulatory challenges that could impact future performance. Overall, the consensus seems to lean towards buying the dip, with the belief that Eli Lilly's long-term prospects remain strong.

Read the Full AOL Article at:
[ https://www.aol.com/finance/buy-dip-eli-lilly-stock-100500713.html ]

Publication Contributing Sources